Trial Profile
Safety and efficacy of Romiplostim in post-chemotherapy thrombocytopenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions; Therapeutic Use
- 13 Sep 2016 New trial record